Skip to main content

Table 4 Target groups for prophylaxis with publicly purchased antivirals (n = 25).

From: Public health management of antiviral drugs during the 2009 H1N1 influenza pandemic: a survey of local health departments in California

  Size of Population Served   
  Small (< 50,000) Medium (50,000-499,999) Large (500,000+) All LHDs
Eligible Group n (%) n (%) n (%) n (%)
Household members of persons with H1N1 influenza 3 (100) 10 (77) 4 (44) 17 (68)
Persons at high-risk for medical complications of influenza (e.g. pregnant women) 3 (100) 4 (31) 5 (56) 12 (48)
Healthcare workers 2 (67) 4 (31) 3 (33) 9 (36)
Other first responders 2 (67) 1 (8) 1 (11) 4 (16)
Household members of healthcare workers 1 (33) 0 (0) 1 (11) 2 (8)
Other 0 (0) 3 (23) 3 (33) 6 (24)
Don't know/Unable to answer 0 (0) 2 (15) 2 (22) 4 (16)
Total 3   13   9   25  
  1. Among the twenty-five local health departments (LHDs) reporting that publicly purchased antivirals could be used for pre- or post-prophylaxis, Table 4 summarizes the groups eligible for prophylaxis with publicly purchased antivirals, stratified by size of population served by LHD
  2. **Indicates statistically significant difference with respect to population size served by LHD (Fisher's exact test, p < .05)
\